Thyrocare (THYROCARE) | Stock Overview & Key Data
Thyrocare Performance Comparison
Stock Range
Today's Range
Low: ₹1,314.00
High: ₹1,369.90
on August 8, 2025
52 Week Range
Low: ₹658.00
High: ₹1,375.00
on March 4, 2025
on August 1, 2025
All-Time High: ₹1,465.00 on June 21, 2021
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR71.3B
EPS
19.94
P/E Ratio (TTM)
67.51
Forward P/E
57.78
P/B Ratio
13.05
PEG Ratio
57.78
Div. Yield
2.97%
ROE
16.73%
Beta
0.236
Debt to Equity
4.51
Financial Highlights
Profitability
Gross Margin
71.18%
Operating Margin
24.02%
Profit Margin
14.69%
Returns and Earnings
Return on Assets (TTM)
13.21%
Return on Equity (TTM)
16.73%
EBITDA
INR2.1B
Net Income (TTM)
INR1.1B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR136.52
Quarterly Revenue Growth (YoY)
23.00%
Quarterly Earnings Growth (YoY)
61.10%
Dividend Information
Last 12-Month Dividend
₹39.00
Current Dividend Yield
2.97%
3-Year Average Dividend Yield
2.51%
3-Year Average Annual Dividend
₹19.00
3-Year Total Dividends
₹57.00
Ex-Dividend Date
July 25, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Thyrocare THYROCARE | 71.34B Mid-cap | 1.26% | 25.18% | 47.77% | 71.98% | 45.08% | 65.86% | 115.09% | 89.72% |
| Syngene SYNGENE | 280.43B Large-cap | -6.83% | 3.58% | 7.29% | -11.01% | -25.48% | -22.04% | 10.74% | 31.92% |
| Dr. Lal PathLabs LALPATHLAB | 268.13B Large-cap | 0.41% | 10.77% | 14.95% | 15.06% | 4.50% | -0.66% | 30.89% | 71.26% |
| Sai Life Sciences SAILIFE | 165.96B Mid-cap | 5.06% | 5.26% | 17.03% | 15.41% | 9.22% | 17.66% | 17.66% | 17.66% |
| Vijaya Diagnostic VIJAYA | 110.12B Mid-cap | -2.67% | 5.23% | 5.45% | -3.97% | -0.79% | 27.14% | 196.35% | 68.17% |
| Metropolis METROPOLIS | 103.34B Mid-cap | -1.44% | 7.63% | 20.76% | 11.75% | -2.34% | -2.41% | 35.43% | 19.95% |
Ownership & Short Interest
Insider Ownership
71.16%
Institutional Ownership
14.01%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
344K
Average 90-Day Volume
177K
Thyrocare Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Thyrocare would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is THYROCARE's 52-week high and low?
- In the last 52 weeks, Thyrocare reached a high of ₹1,375.00 (on August 1, 2025) and a low of ₹658.00 (on March 4, 2025).
- What is the market cap and P/E ratio for THYROCARE?
- Curious about Thyrocare's size and valuation? Its market capitalization stands at 71.34B. When it comes to valuation, the P/E ratio (trailing twelve months) is 67.51, and the forward P/E (looking ahead) is 57.78.
- Does THYROCARE pay dividends? If so, what's the yield?
- Yes, Thyrocare is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.97%, and the company has paid an average of ₹19.00 per share annually over the past 3 years.
- Who are Thyrocare's main competitors or similar companies to consider before investing?
When looking at Thyrocare, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Syngene
SYNGENE280.43B Healthcare Diagnostics & Research -22.04% 10.74% Dr. Lal PathLabs
LALPATHLAB268.13B Healthcare Diagnostics & Research -0.66% 30.89% Sai Life Sciences
SAILIFE165.96B Healthcare Diagnostics & Research 17.66% 17.66% Vijaya Diagnostic
VIJAYA110.12B Healthcare Diagnostics & Research 27.14% 196.35% Metropolis
METROPOLIS103.34B Healthcare Diagnostics & Research -2.41% 35.43% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Thyrocare Technologies Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Thyrocare's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 16.73%, the Debt to Equity ratio from the most recent quarter is 4.51, and its Gross Profit Margin stands at 71.18%.
- What is the recent revenue and earnings growth for THYROCARE?
- Looking at Thyrocare's growth, its revenue over the trailing twelve months (TTM) was INR7B. Compared to the same quarter last year (YoY), quarterly revenue grew by 23.00%, and quarterly earnings saw a YoY growth of 61.10%.
- How much of THYROCARE stock is held by insiders and institutions?
- Wondering who owns Thyrocare stock? Company insiders (like executives and directors) hold about 71.16% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 14.01%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.